|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||0.00 - 0.00|
|Beta (5Y monthly)||2.18|
|PE ratio (TTM)||7.66|
|Earnings date||07 Mar 2023 - 13 Mar 2023|
|Forward dividend & yield||N/A (N/A)|
|Ex-dividend date||29 Aug 2019|
|1y target est||0.75|
LONDON (Reuters) -Capricorn investor Palliser Capital said on Thursday it opposed Capricorn's planned merger with Israel's NewMed Energy, echoing its criticism of a previous failed merger plan with Tullow, as undervaluing the company. The Capricorn-NewMed deal would create an Israel-Egypt-focused gas producer including NewMed's stake in Israel's giant Leviathan offshore field at a time when Europe is looking for non-Russian energy supplies. It includes a $620 million special dividend to Capricorn shareholders.
Apart from Shell (SHEL) and APA Corporation (APA), Chevron (CVX), Tullow Oil (TUWOY) and Northern Oil & Gas (NOG) hogged the limelight during the week.